ALPINE 4 HOLDINGS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.49 USD | -3.73% |
|
-12.50% | -33.33% |
| 05-17 | Alpine 4 Holdings Gets Delisting Determination From Nasdaq | MT |
| 2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
8708a47ad627dfacdc10bfb37c.OYmZ3ocOehTFq6UD2X8_qum_IahLlmfVw7gB3ZKZI8I.Vvmtn_VDP2P855ZZjCd96If0V8YZ2R-HhdNT7qbLdvBb8M3swn41dpOc7A~00aaa0c0c5e1f31a30741697cc42aa9f
